University Hospital, Strasbourg, France
Clinical trials sponsored by University Hospital, Strasbourg, France, explained in plain language.
-
Balloon treatment for sinusitis may offer faster recovery and less pain
Symptom relief TerminatedThis study compared a newer, less invasive procedure called balloon sinuplasty to standard surgery for people with frontal sinusitis that did not improve with medication. The balloon procedure uses a small catheter to open blocked sinus passages, aiming to reduce pain, bleeding, …
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
VR hypnosis may replace laughing gas for scared kids at the dentist
Symptom relief TerminatedThis study tested whether virtual reality hypnosis can reduce anxiety and pain in children during dental procedures as effectively as nitrous oxide (laughing gas). Thirty anxious children aged 7 to 10 took part. Researchers measured their behavior and pain levels to compare the t…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Morphine gel may offer direct relief for chemo mouth sores
Symptom relief TerminatedThis study tested a morphine gel applied directly to painful mouth sores caused by chemotherapy. The goal was to see if the gel could relieve pain better than morphine given through an IV. The study included children and young adults aged 5 to 25. The gel was applied four times a…
Phase: PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Brain scans guide depression therapy in new pilot study
Symptom relief TerminatedThis pilot study tested whether using brain scans to personalize magnetic stimulation (rTMS) could improve treatment for people with depression that hasn't responded to medication. 27 participants received either personalized rTMS, standard rTMS, or a different type of brain stim…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
MRI scans aim to predict tysabri success in MS patients
Knowledge-focused TerminatedThis study looked at whether special MRI scans can detect early brain changes in people with multiple sclerosis who are starting treatment with Tysabri. Researchers planned to follow 70 patients for two years, comparing MRI images before and after treatment. The goal was to find …
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Lupus and COVID vaccines: immune response under the microscope
Knowledge-focused TerminatedThis study aimed to understand how the COVID-19 vaccine impacts the immune system in people with lupus, a chronic autoimmune disease. Researchers planned to enroll lupus patients to measure their immune response to the vaccine and see if lupus disease activity or treatments affec…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Which rehab works best after shoulder surgery? study aims to find out.
Knowledge-focused TerminatedThis study compared three different rehabilitation programs after arthroscopic rotator cuff repair. Participants were divided into groups with varying periods of immobilization and passive motion before starting active rehab. The goal was to see which program leads to the best sh…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Brain zaps reveal clues about epilepsy treatment
Knowledge-focused TerminatedThis study looked at how a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) changes brain activity in people with hard-to-treat frontal lobe epilepsy. Researchers measured brain excitability before and after stimulation to unders…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
HIV drugs may weaken bones: new study investigates
Knowledge-focused TerminatedThis study looked at bone density in HIV-positive men to see if antiretroviral drugs cause bone thinning. Researchers compared men starting HIV treatment with those not yet on therapy over two years. The goal was to understand why bone loss is more common in HIV patients.
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC